Anti-Human CD59 Rabbit Recombinant Antibody 98099-1-RR proteintech

$68.00
In stock
SKU
98099-1-RR
Catalog No.SizePrice (USD)
98099-1-RR-100UG100 μg$68.00
Custom$0.00
Catalog Number98099-1-RR
Synonyms20 kDa homologous restriction factor, 241311A4, CD 59, CD59 antigen, CD59 glycoprotein
HostRabbit
Reactivityhuman
FormLiquid
FormulationPBS, Azide
ApplicationsFC
Host / IsotypeRabbit / IgG
Tested Applications — Positive FC detected inhuman PBMCs
Positive FC detected inhuman PBMCs
Flow Cytometry (FC)FC : 0.25 ug per 10^6 cells in 100 μl suspension
Tested Reactivityhuman
ClassRecombinant
TypeAntibody
ImmunogenRecombinant Protein Predict reactive species
Full NameCD59 molecule, complement regulatory protein
Calculated Molecular Weight19 kDa
GenBank Accession NumberBC001506
Gene SymbolCD59
Gene ID (NCBI)966
RRIDAB_3672246
ConjugateUnconjugated
Purification MethodProtein A purfication
UNIPROT IDP13987
Storage BufferPBS with 0.09% sodium azide, pH 7.3.
Storage ConditionsStore at 2 - 8°C. Stable for one year after shipment.
FC protocol for CD59 antibody 98099-1-RRDownload protocol
Citations-
IsotypeIgG
ClonalityRecombinant
Clone Number241311A4
ConjugationUnconjugated

CD59, also named as MIC11, MIN1, MIN2, MIN3, MSK21, MIRL, MACIF, HRF20 and 1F5 antigen, is a cell surface molecule glycoprotein with MW 18-25 kDa. It acts as a determinant of proximal-distal cell identity. CD59 acts by binding to the C8 and/or C9 complements of the assembling membrane attack complex (MAC), thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. It is involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. Protocols Product Specific Protocols FC protocol for CD59 antibody 98099-1-RR Download protocol Standard Protocols Click here to view our Standard Protocols

Product Documents

Datasheet

Reviews

Write Your Own Review
You're reviewing:Anti-Human CD59 Rabbit Recombinant Antibody 98099-1-RR proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.